Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus

References

• Wen ZK, Xu W, Xu L, et al. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 2007;46:1796–1803
   PubMed Web of Science ®Google Scholar
• Perry D, Sang A, Yin Y, et al. Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011;2011:271694
   PubMedGoogle Scholar
• Gurevitz, Samuel L. Snyder, Jennifer A, Wessel Eric K, Frey. Systemic lupus erythematosus – a review of the disease and treatment opti. Consultant Pharm 2013;2
   Google Scholar
• Gurevitz S, Snyder J, Wessel E, et al. Systemic lupus erythematosus: a review of the diseaseand treatment options. Consultant Pharm 2013;28:110–121
   PubMedGoogle Scholar
• Borba VZC, Vieira JGH, Kasamatsu T, et al. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009;20:427–433
   PubMed Web of Science ®Google Scholar
• Benrashid M, Moyers K, Mohty M, Savani BN. Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy. Exp Hematol 2012;40:263–267
   PubMed Web of Science ®Google Scholar
• Hewison M. An update on vitamin D and human immunity. Clin Endocrinol 2012;76:315–325
   PubMed Web of Science ®Google Scholar
• Mok CC. Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol 2013;9:453–463
   PubMed Web of Science ®Google Scholar
• Mok CC, Birmingham DJ, Ho LY, et al. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus 2012;21:36–42
   PubMed Web of Science ®Google Scholar
• Weigert O, von Spee C, Undeutsch R, et al. CD4+Foxp3+regulatory T cells prolong drug–induced disease remission in (NZBxNZW) F1 lupus mice. Arthritis Res Ther 2013;15:R35
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Wing K, Onishi Y, et al. Regulatory T cells: how do they suppress immune responses? Int Immunol 2009;21:1105–1111
   PubMed Web of Science ®Google Scholar
• Sekiya T, Kashiwagi I, Inoue N, et al. The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4 + T cells. Nat commun 2011;2:269
   PubMed Web of Science ®Google Scholar
• Mudd PA, Teague BN, Farris AD. Regulatory T cells and systemic lupus erythematosus. Scand J Immunol 2006;64:211–218
   PubMed Web of Science ®Google Scholar
• Lee H-M, Sugino H, Nishimoto N. Cytokine networks in systemic lupus erythematosus. J Biomed Biotechnol 2010;2010:676284
   PubMedGoogle Scholar
• Luo CT, Li MO. Transcriptional control of regulatory T cell development and function. Trends Immunol 2013;34:531–539
   PubMed Web of Science ®Google Scholar
• Pan Y, Sawalha AH. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res 2009;153:4–10
   PubMed Web of Science ®Google Scholar
• Richardson B. DNA methylation and autoimmune disease. Clin Immunol 2003;109:72–79
   PubMed Web of Science ®Google Scholar
• Rottman JB, Willis CR. Mouse models of systemic lupus erythematosus reveala complex pathogenesis. Vet Pathol 2010;47:664–676
   PubMed Web of Science ®Google Scholar
• Lemire JM, Ince A, Takashima M. 1,25-Dihydroxyvitamin D3 attenuates of expression of experimental murine lupus of MRL/1 Mice. Autoimmunity 1992;12:143–148
   PubMed Web of Science ®Google Scholar
• Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579–2585
   PubMed Web of Science ®Google Scholar
• Koizumi T, Nakao Y, Matsui T, et al. Effects of corticosteroid and 1,24-R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice. Int Arch Allergy Appl Immunol 1985;77:396–404
   PubMedGoogle Scholar
• Tang B, Matsuda T, Akira S, et al. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 1991;3:273–278
   PubMed Web of Science ®Google Scholar
• Cash H, Relle M, Menke J, et al. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol 2010;37:60–70
   PubMed Web of Science ®Google Scholar
• Liang B, Gardner DB, Griswold DE, et al. Anti-interleukin-6 monoclonal antibody inhibits autoimmuneresponses in a murine model of systemic lupus erythematosus. Immunology 2006;119:296–305
   PubMed Web of Science ®Google Scholar
• Blenman KR, Duan B, Xu Z, et al. IL-10 regulation of lupus in the NZM2410 murine model. Lab Investig 2006;86:1148–11136
   Web of Science ®Google Scholar
• Lacki J, Samborski W, Mackiewicz S. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin Rheumatol 1997;16:275–278
   PubMed Web of Science ®Google Scholar
• Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009;132:1146–1160
   PubMed Web of Science ®Google Scholar
• Ohtsuka T. Serum interleukin-6 level is reflected in elevated high-sensitivity C-reactive protein level in patients with systemic sclerosis. J Dermatol 2010;37:801–806
   PubMed Web of Science ®Google Scholar
• Sfikakis P, Souliotis VL, Fragiadaki K, et al. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol 2007;123:66–73
   PubMed Web of Science ®Google Scholar
• Miyara M, Amoura Z, Parizot C, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005;175:8392–8400
   PubMed Web of Science ®Google Scholar
• Scalapino K, Tang Q, Bluestone J, et al. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 2006;177:1451–1459
   PubMed Web of Science ®Google Scholar
• Bell SE, Goodnow CC. A selective defect in IgM antigenreceptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J 1994;13:816–826
   PubMed Web of Science ®Google Scholar
• Finkelman RD, Linkhart TA, Mohan S, et al. Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. Proc Natl Acad Sci 1991;88:3657–3660
   PubMed Web of Science ®Google Scholar
• Terrier B, Derian N, Schoindre Y, et al. Restoration ofregulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 2012;14:R221
   PubMed Web of Science ®Google Scholar
• Urry Z, Chambers ES, Xystrakis E, et al. The role of 1α, 25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+and IL-10+CD4+T cells. Eur J Immunol 2012;42:2697–2708
   PubMed Web of Science ®Google Scholar